Lactylation-mediated miRNA regulation in cancer therapy resistance
Abstract Therapeutic resistance in cancer is increasingly understood as a dynamic outcome of the interplay among tumour metabolism, epigenetic regulation, and immune modulation, rather than a consequence of genetic mutations alone. At this intersection, lactylation-a recently discovered lactate-deri...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06959-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849225963345281024 |
|---|---|
| author | Yiyi Shou Ruiqi Liu Hao Xiong Xiaoyan Chen Luanluan Huang Ran Huang Hailong Sheng Haibo Zhang Yanwei Lu Haiwei Guo |
| author_facet | Yiyi Shou Ruiqi Liu Hao Xiong Xiaoyan Chen Luanluan Huang Ran Huang Hailong Sheng Haibo Zhang Yanwei Lu Haiwei Guo |
| author_sort | Yiyi Shou |
| collection | DOAJ |
| description | Abstract Therapeutic resistance in cancer is increasingly understood as a dynamic outcome of the interplay among tumour metabolism, epigenetic regulation, and immune modulation, rather than a consequence of genetic mutations alone. At this intersection, lactylation-a recently discovered lactate-derived post-translational modification (PTM)-acts as a molecular bridge linking metabolic rewiring to transcriptional and post-transcriptional control. Meanwhile, microRNAs (miRNAs) have emerged as essential regulators of metabolic adaptation and epigenetic plasticity. However, the interaction between lactylation and miRNA networks remains largely underexplored. Herein, we present a comprehensive and structured assessment of this emerging interdisciplinary field. We begin with a focused overview of tumour metabolic reprogramming and the enzymology of lactylation, establishing the biochemical context for its regulatory functions. We then examine how miRNAs interpret and reinforce metabolic cues, particularly through three interrelated regulatory frameworks. Lactylation of histones and DNA repair proteins has been shown to activate oncogenic miRNA clusters; these same miRNAs, in turn, enhance glycolytic flux and fine-tune the activity of lactylation enzymes, forming bidirectional feedback loops. Under stress conditions such as hypoxia or chemotherapy, lactate accumulation selectively suppresses DNA-repair-targeting and Pro-apoptotic miRNAs, stabilising BRCA1/RAD51-mediated repair programs. Furthermore, lactylation-dependent miRNA signals disseminate via extracellular vesicles, contributing to T cell exhaustion and macrophage M2 polarisation, thus shaping an immunosuppressive tumour microenvironment. Based on these converging mechanisms, we highlight potential therapeutic strategies, including the co-targeting of LDHA and oncogenic miRNAs (e.g., nanoparticle-mediated delivery of anti-miR-21), as well as liquid biopsy-based monitoring of circulating H3K18la and miRNA signatures to predict emerging resistance. By integrating metabolic, epigenetic, and immunologic perspectives, we position lactylation-miRNA crosstalk as a central regulatory axis in cancer therapy resistance and offer a conceptual framework to inform the development of future mechanism-driven interventions. |
| format | Article |
| id | doaj-art-0ff364cae48c4ed8acb60aadca13a6da |
| institution | Kabale University |
| issn | 1479-5876 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Translational Medicine |
| spelling | doaj-art-0ff364cae48c4ed8acb60aadca13a6da2025-08-24T11:48:19ZengBMCJournal of Translational Medicine1479-58762025-08-0123111610.1186/s12967-025-06959-5Lactylation-mediated miRNA regulation in cancer therapy resistanceYiyi Shou0Ruiqi Liu1Hao Xiong2Xiaoyan Chen3Luanluan Huang4Ran Huang5Hailong Sheng6Haibo Zhang7Yanwei Lu8Haiwei Guo9Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeDepartment of Pathology, Tongde Hospital of Zhejiang ProvinceCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeSchool of Clinical Medicine, Hangzhou Normal UniversityCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeCancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeOtolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeAbstract Therapeutic resistance in cancer is increasingly understood as a dynamic outcome of the interplay among tumour metabolism, epigenetic regulation, and immune modulation, rather than a consequence of genetic mutations alone. At this intersection, lactylation-a recently discovered lactate-derived post-translational modification (PTM)-acts as a molecular bridge linking metabolic rewiring to transcriptional and post-transcriptional control. Meanwhile, microRNAs (miRNAs) have emerged as essential regulators of metabolic adaptation and epigenetic plasticity. However, the interaction between lactylation and miRNA networks remains largely underexplored. Herein, we present a comprehensive and structured assessment of this emerging interdisciplinary field. We begin with a focused overview of tumour metabolic reprogramming and the enzymology of lactylation, establishing the biochemical context for its regulatory functions. We then examine how miRNAs interpret and reinforce metabolic cues, particularly through three interrelated regulatory frameworks. Lactylation of histones and DNA repair proteins has been shown to activate oncogenic miRNA clusters; these same miRNAs, in turn, enhance glycolytic flux and fine-tune the activity of lactylation enzymes, forming bidirectional feedback loops. Under stress conditions such as hypoxia or chemotherapy, lactate accumulation selectively suppresses DNA-repair-targeting and Pro-apoptotic miRNAs, stabilising BRCA1/RAD51-mediated repair programs. Furthermore, lactylation-dependent miRNA signals disseminate via extracellular vesicles, contributing to T cell exhaustion and macrophage M2 polarisation, thus shaping an immunosuppressive tumour microenvironment. Based on these converging mechanisms, we highlight potential therapeutic strategies, including the co-targeting of LDHA and oncogenic miRNAs (e.g., nanoparticle-mediated delivery of anti-miR-21), as well as liquid biopsy-based monitoring of circulating H3K18la and miRNA signatures to predict emerging resistance. By integrating metabolic, epigenetic, and immunologic perspectives, we position lactylation-miRNA crosstalk as a central regulatory axis in cancer therapy resistance and offer a conceptual framework to inform the development of future mechanism-driven interventions.https://doi.org/10.1186/s12967-025-06959-5CancerMiRNALactylationTherapy resistanceMetabolic reprogrammingImmune modulation |
| spellingShingle | Yiyi Shou Ruiqi Liu Hao Xiong Xiaoyan Chen Luanluan Huang Ran Huang Hailong Sheng Haibo Zhang Yanwei Lu Haiwei Guo Lactylation-mediated miRNA regulation in cancer therapy resistance Journal of Translational Medicine Cancer MiRNA Lactylation Therapy resistance Metabolic reprogramming Immune modulation |
| title | Lactylation-mediated miRNA regulation in cancer therapy resistance |
| title_full | Lactylation-mediated miRNA regulation in cancer therapy resistance |
| title_fullStr | Lactylation-mediated miRNA regulation in cancer therapy resistance |
| title_full_unstemmed | Lactylation-mediated miRNA regulation in cancer therapy resistance |
| title_short | Lactylation-mediated miRNA regulation in cancer therapy resistance |
| title_sort | lactylation mediated mirna regulation in cancer therapy resistance |
| topic | Cancer MiRNA Lactylation Therapy resistance Metabolic reprogramming Immune modulation |
| url | https://doi.org/10.1186/s12967-025-06959-5 |
| work_keys_str_mv | AT yiyishou lactylationmediatedmirnaregulationincancertherapyresistance AT ruiqiliu lactylationmediatedmirnaregulationincancertherapyresistance AT haoxiong lactylationmediatedmirnaregulationincancertherapyresistance AT xiaoyanchen lactylationmediatedmirnaregulationincancertherapyresistance AT luanluanhuang lactylationmediatedmirnaregulationincancertherapyresistance AT ranhuang lactylationmediatedmirnaregulationincancertherapyresistance AT hailongsheng lactylationmediatedmirnaregulationincancertherapyresistance AT haibozhang lactylationmediatedmirnaregulationincancertherapyresistance AT yanweilu lactylationmediatedmirnaregulationincancertherapyresistance AT haiweiguo lactylationmediatedmirnaregulationincancertherapyresistance |